跳至主要内容
临床试验/CTRI/2023/11/059467
CTRI/2023/11/059467尚未招募Unknown

To evaluate the in-vivo safety and efficacy of Hair care formulation in terms of reduction in hair fall and improvement in hair growth (Hair Length) on healthy female subjects. - NI

Vansaar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Indian female subjects.
  • 2)Healthy subjects
  • 3)Skin & scalp is healthy on the studied anatomic unit
  • 4) Having moderate to severe hair fall

排除标准

  • 1)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
  • 2) Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • 3) Being epileptic
  • 4) Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • 5) Having cutaneous hypersensitivity
  • 6) Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products
  • 7) Following a chronic or intermittent medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
  • 8) Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months
  • 9) Having changed his/her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.
  • 10) Having applied a hair care product and cosmetic product on the studied area as well as on the face the first day of the study (except the neutral shampoo without anti hairfall claim or hair growth claim)
  • 11)Having naturally fair or white hair (Which will interfere the evaluation)
  • 12)Having a dermatosis on the scalp
  • 13)Having surgery history on the scalp (micro transplants)
  • 14)Refusing the bleaching of two areas of the scalp of approx. 40 hairs, the first day of the study.
  • 15)Refusing the pluking of approx. 10 hairs, during the entire study
  • 16)Having presented a factor inducing a telogen effluvium in the 3 months preceding the start of the study (delivery, important stress, high fever)

研究者

发起方
Vansaar

相似试验